Irvine、CAにおける膀胱癌の臨床試験
Irvineとその周辺地域（約30マイル以内）の拠点で、膀胱癌に関する11件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
被験者募集中第3相
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
被験者募集中第2相
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
被験者募集中第1相
- City of Hope at Irvine Lennar, Irvine
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
被験者募集中第2相
- City of Hope at Irvine Lennar, Irvine
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
被験者募集中第1/2相
- UCLA Hematology/Oncology - Irvine, Irvine
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
- 他2件
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
被験者募集中第3相
- Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
被験者募集中第2相
- City of Hope, Irvine
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
被験者募集中第3相
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
被験者募集中第1/2相
- University of California - Irvine Medical Center, Irvine
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
被験者募集中第2相
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Kaiser Permanente Alton/Sand Canyon Medical Offices, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Irvine
他の都市における膀胱癌の試験
- New York City, NY35件の研究
- Nashville, TN31件の研究
- Houston, TX31件の研究
- Dallas, TX27件の研究
- Boston, MA26件の研究
- Washington, DC26件の研究
- Los Angeles, CA24件の研究
- Baltimore, MD24件の研究
- St. Louis, MO22件の研究
- Philadelphia, PA21件の研究
- Seattle, WA21件の研究
- Edison, NJ21件の研究
Irvineにおける他の研究
- 非小細胞肺癌25件の研究
- 乳がん23件の研究
- がん（全種類）16件の研究
- 転移性癌16件の研究
- 肺がん15件の研究
- 多発性骨髄腫14件の研究
- 前立腺がん14件の研究
- 卵巣がん12件の研究
- アルツハイマー病11件の研究
- 頭頸部扁平上皮癌11件の研究
- 大腸癌10件の研究
- 膵臓がん10件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。